Cross-border collaboration—building the future of global health together.

MXBIO, Inc. is expanding its global business through strategic partnerships 

tailored to the market characteristics and healthcare environments of each region.


Overseas Collaboration Partners

Southeast Asia (Thailand, Vietnam, etc.)

At the center of Asia’s fast-growing dental market, we are building locally tailored clinical collaborations and service networks to accelerate market penetration.


  • Partnership with NueMedi
  • We advance local clinical and business collaborations based on rapidly growing implant markets and strong demand for dental care.

China

In China—home to one of the world’s largest implant markets—we are securing long-term business momentum and strengthening our local presence through strategic partnerships.


  • Partnership with C.C Dental
  • We are driving mid- to long-term expansion leveraging China’s large-scale implant procedure market.

Partnership Model

MXBIO, Inc. operates flexible partnership models tailored to each region and partner’s business environment.


  • Technology Licensing: Out-licensing and scaling our proprietary biomaterial technologies to global markets
  • Co-development: Developing next-generation treatment solutions with global research institutions and industry partners
  • Exclusive Supply (Regional): Global distribution of high-quality medical devices and pharmaceuticals through a stable supply network


Through these models, we maximize our technological competitiveness and build a sustainable global business structure.


Global Market–Focused Strategy

MXBIO, Inc. is not limited to the domestic market. We define overseas expansion—supported by partnerships across Asia and beyond—as a core growth strategy.
Leveraging our technological strengths, we actively pursue licensing, co-development, and exclusive supply models, steadily expanding our presence in the global dental and biotech markets.


Innovation at MXBIO, Inc. never stops.
Together with partners worldwide, we connect and scale new value across our biomaterials platform.

Cross-border collaboration—building the future of global health together.

MXBIO, Inc. is expanding its global business

through strategic partnerships tailored 

to the market characteristics and healthcare environments of each region.


Overseas Collaboration Partners


Southeast Asia (Thailand, Vietnam, etc.)


At the center of Asia’s fast-growing dental market, we are building locally tailored clinical collaborations and service networks to accelerate market penetration.


  • Partnership with NueMedi
  • We advance local clinical and business collaborations based on rapidly growing implant markets and strong demand for dental care.

China


In China—home to one of the world’s largest implant markets—we are securing long-term business momentum and strengthening our local presence through strategic partnerships.


  • Partnership with C.C Dental
  • We are driving mid- to long-term expansion leveraging China’s large-scale implant procedure market.

Partnership Model


MXBIO, Inc. operates flexible partnership models tailored to each region and partner’s business environment.


  • Technology Licensing: Out-licensing and scaling our proprietary biomaterial technologies to global markets
  • Co-development: Developing next-generation treatment solutions with global research institutions and industry partners
  • Exclusive Supply (Regional): Global distribution of high-quality medical devices and pharmaceuticals through a stable supply network


Through these models, we maximize our technological competitiveness and build a sustainable global business structure.


Global Market–Focused Strategy


MXBIO, Inc. is not limited to the domestic market. We define overseas expansion—supported by partnerships across Asia and beyond—as a core growth strategy.
Leveraging our technological strengths, we actively pursue licensing, co-development, and exclusive supply models, steadily expanding our presence in the global dental and biotech markets.


Innovation at MXBIO, Inc. never stops.
Together with partners worldwide,

we connect and scale new value across our biomaterials platform.